Full article: Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring® (etonogestrel/ethinylestradiol 11.7/2.7 mg)
![Pharmaceutics | Free Full-Text | The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings | HTML Pharmaceutics | Free Full-Text | The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-00751/article_deploy/html/images/pharmaceutics-13-00751-g002.png)
Pharmaceutics | Free Full-Text | The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings | HTML
![Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India - Contraception Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India - Contraception](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8b698420-b2aa-4fcf-b581-d0a0ddeb4d22/gr4_lrg.jpg)
Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India - Contraception
![Color, Scent and Size: Exploring Women's Preferences Around Design Characteristics of Drug-Releasing Vaginal Rings | SpringerLink Color, Scent and Size: Exploring Women's Preferences Around Design Characteristics of Drug-Releasing Vaginal Rings | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10461-022-03596-7/MediaObjects/10461_2022_3596_Fig1_HTML.png)
Color, Scent and Size: Exploring Women's Preferences Around Design Characteristics of Drug-Releasing Vaginal Rings | SpringerLink
![PDF) Pharmacokinetic bioequivalence, safety and acceptability of Ornibel ® , a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring ® (etonogestrel/ethinylestradiol 11.7/2.7 mg) PDF) Pharmacokinetic bioequivalence, safety and acceptability of Ornibel ® , a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring ® (etonogestrel/ethinylestradiol 11.7/2.7 mg)](https://www.researchgate.net/profile/Pedro-Antonio-Regidor/publication/322536735/figure/fig7/AS:631624228159523@1527602359630/Etonogestrel-and-ethynilestradiol-mean-plasma-concentration-time-curves-4-weeks-of-use_Q320.jpg)
PDF) Pharmacokinetic bioequivalence, safety and acceptability of Ornibel ® , a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring ® (etonogestrel/ethinylestradiol 11.7/2.7 mg)
![Montmorillonite-based polyacrylamide hydrogel rings for controlled vaginal drug delivery - ScienceDirect Montmorillonite-based polyacrylamide hydrogel rings for controlled vaginal drug delivery - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0928493119317503-ga1.jpg)